Investor FAQs

What is Astria’s official name?
Astria Therapeutics, Inc.
Astria was formally known as Catabasis Pharmaceuticals, Inc. prior to a name change on September 8, 2021.
Where are Astria’s corporate headquarters?
100 High Street, 28th Floor
Boston, MA 02110
 
When was the company founded?
The company was founded in 2008.
 
Where is Astria incorporated?
Astria is incorporated under the laws of the State of Delaware.
 
Where is Astria’s common stock listed and what is the ticker symbol?
Astria’s stock is listed on the NASDAQ Global Market under the ticker ATXS.
 
When did Astria go public?
The company went public though an IPO and began trading on the NASDAQ Global Market on June 26, 2015.
 
When does Astria’s fiscal year end?
Astria’s fiscal year-end is on December 31.
 
Who is Astria’s transfer agent and how do I contact them?
American Stock Transfer & Trust Company.  Please contact them at American Stock Transfer and Trust Company, Shareholder Services Department, 6201 15th Avenue, Brooklyn, NY 11219 (telephone: 718-921-8214 or 800-937-5449) or visit www.amstock.com.
 
Who do I contact regarding questions or changes to my stock certificates?
Please contact Astria’s transfer agent.
 
Who are Astria’s independent auditors?
Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116
 
Who is Astria’s legal counsel?
Mr. Ben Harshbarger, J.D. is Astria’s Chief Legal Officer. Astria’s outside corporate legal counsel is Rosemary Reilly, WilmerHale, LLP.
 
Where can I view Astria’s documents filed with the Securities and Exchange Commission?
Astria’s SEC Filings can be found here.
 
Whom should I contact if I have further questions?
Andrea Matthews
investors@astriatx.com